Elizabeth George

University of California, San Francisco

Papers

1

Total Citations

21

H-Index

1

About

Elizabeth George is a leading surgical oncologist whose research focuses on refining treatment paradigms for HPV-positive oropharyngeal squamous cell carcinoma (OPSCC). Her major contributions center on personalizing surgical decision-making through transoral robotic surgery (TORS), particularly in understanding patient-specific risks. Her landmark 2021 study, cited 21 times, systematically analyzed the likelihood of adverse histopathologic features—such as pathologic extranodal extension—following primary TORS for HPV-positive OPSCC. This work provides critical data to guide preoperative consultations, helping surgeons and patients weigh the risks of occult high-risk pathology against the benefits of minimally invasive surgery. By quantifying these probabilities, George’s research directly informs clinical practice, enabling more tailored treatment plans that may reduce overtreatment or undertreatment. Her work bridges the gap between surgical technique and oncologic outcomes, offering evidence-based insights that empower shared decision-making. Through her focused investigations, George has established herself as a key voice in the evolving landscape of HPV-related head and neck cancer management, where her findings continue to shape how surgeons approach risk stratification and patient counseling in the TORS era.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer
21 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago